期刊文献+

IL-17在原发性干燥综合征患者外周血中的表达及临床意义 被引量:2

Expression and clinical significance of IL-17 in peripheral blood of pati ents with primary Sjogren’s syndrome
下载PDF
导出
摘要 目的:探讨并研究白细胞介素-17(IL-17)在原发性干燥综合征(pSS)患者外周血中的表达及临床意义。方法:选择滁州市第一人民医院收治的42例pSS患者与同期在该医院进行体检的30例健康人作为研究对象。将其中42例pSS患者作为观察组,将其中的30例健康人作为对照组。对两组研究对象外周血中IL-17的水平进行检测,并将观察组患者分为初发组、稳定组和复发组,比较各组患者外周血中IL-17的水平,同时分析pSS患者外周血中IL-17的浓度与其免疫球蛋白G(IgG)的水平及红细胞沉降率(ESR)的关系。结果:观察组患者外周血中IL-17的水平高于对照组健康人,P<0.05。在观察组患者中,初发组患者与复发组患者外周血中IL-17的水平均高于稳定组患者,P<0.05;初发组患者与复发组患者外周血中IL-17的水平相比,P>0.05。通过进行Pearson相关性分析得知,pSS患者外周血中IL-17的浓度与其IgG的水平和ESR均呈正相关(r=0.678,P<0.05;r=0.634,P<0.05)。结论:IL-17在pSS患者外周血中的表达水平较高,此病患者外周血中IL-17的浓度与其IgG的水平及ESR呈正相关。外周血中IL-17表达水平的升高可能与pSS的发生发展存在一定的相关性。 Objective:To investigate the expression of interleukin-17(IL-17)in peripheral blood of patients with primary Sjogren’s syndrome(PSS)and its clinical significance.Methods:42 cases of PSS patients admitted to Chuzhou First People’s Hospital and 30 cases of healthy people were selected as the research object.Among them,42 patients with PSS were selected as the observation group,and 30 healthy people were selected as the control group.The level of IL-17 in the peripheral blood of the subjects in the two groups was detected,and the observation group was divided into the primary group,the stable group and the relapsed group.The level of IL-17 in the peripheral blood of the patients in each group was compared,and the relationship between the concentration of IL-17 in the peripheral blood of the patients with PSS and the level of immunoglobulin G(IgG)and the erythrocyte segregating rate(ESR)was analyzed.Results:The level of IL-17 in peripheral blood of observation group was higher than that of control group(P<0.05).In the observation group,the level of IL-17 in peripheral blood of the initial group and the relapse group was higher than that of the stable group,P<0.05;The level of IL-17 in the peripheral blood of the primary group was P>0.05 compared with that of the relapsed group.Pearson correlation analysis showed that the concentration of IL-17 in peripheral blood of PSS patients was positively correlated with the level of IgG and ESR(r=0.678,P<0.05;R=0.634,P<0.05).Conclusion:The expression level of IL-17 in peripheral blood of patients with PSS is higher,and the concentration of IL-17 in peripheral blood of patients with PSS is positively correlated with the level of IgG and ESR.The elevated expression level of IL-17 in peripheral blood may be correlated with the occurrence and development of PSS.
作者 左敏 ZUO Min(Chuzhou First People’s Hospital,Chuzhou,Anhui 239000)
出处 《当代医药论丛》 2021年第10期54-55,共2页
关键词 白细胞介素-17 原发性干燥综合征 免疫球蛋白G 红细胞沉降率 interleukin-17 Primary Sjogren’s syndrome Immunoglobulin G Erythrocyte sedimentation rate
  • 相关文献

参考文献4

二级参考文献24

  • 1Rabadi MN, Kundi S, Brett D, et al. Neurological pictures. Primary SjSgren' s syndrome presenting as neuromyelitis optiea [ J ]. J Neurol Neurosurg Psychiatry ,2010,81 ( 2 ) :213-214.
  • 2Feldmann M, Maini SR. Role of cytokines inrheumatoid arthritis : an ed- ucation in pathophysiology and therapeutics - J ]. Immunological Re- views,2008,223( 1 ) :7-19.
  • 3Dong C. Differentiation and function of pro-inflammatory Thl7 cells [ J ]. Mirobes Infect,2009,11 ( 5 ) :584-588.
  • 4Katsifis GE, Rekka S, Moutsopoulos NM, et al. Systemic and local in- terleukin-17 and linked eytokines associated with Sj6gren' s syndrome immunopathogenesis - J ]. Am J Pathol , 2009 ,17 5 (3) : 1167-1177.
  • 5Nguyen CQ, Yin H, Lee BH, et al. Pathogenic effect of interleukin-17A in induction of Sj6gren' s syndrome-like disease using adenovirus-me- diated gene transfer[ J]. Arthritis Res Ther,2010,12 (6) : R220.
  • 6Nguyen CQ,Yin H,Lee BH ,et al. Pathway in SjiJgren' s syndrome link disease using adenovirus-mediated gene transfer [ J ]. Arthritis Res T- her,2010,12 : R220.
  • 7Van Woerkom JM, Kruize AA, Geenen R, et al. Safety and efficacy of leflunomide inprimary Primary Sjogren' s syndrome : a phase II pilot study[J]. Ann Rheum Dis,2007,66(8):1026-1032.
  • 8Vitali C,Palombi G,Baldini C. Sjogren's syndrome disease damage index and disease activity index:scoring sysems for the assessment of disease damage and disease activity in Sjogren's syndrome,derived from an analysis of a eohort of ltalian patients[J].Arthritis and Rheumatism,2007.2223-2231.
  • 9Bowman SJ,Sutcliffe N,lsenberg DA. Sjogren's systemic clinical activity index(SCAl)--a systemic disease activity measure for use in clinical trials in primary Sjogren's syndrome[J].Rheumatology(Oxford),2007.1845-1851.
  • 10Seror R,Ravaud P,Bowman S. EULAR Sjogren's syndrome disease activity index:development of a consensus systemic disease activity index for primary Sjogren's syndrome[J].Annals of the Rheumatic Diseases,2010.1103-1109.

共引文献489

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部